Lang, Anthony E.
University of Toronto · Toronto Western Hospital
39 papers on CoChatORCID 0000-0003-1229-3667
Most cited papers
- Verified
MDS clinical diagnostic criteria for Parkinson’s disease
Postuma, R. B., Berg, D., Stern, M., Poewe, W., Olanow, C. W., Oertel, W., Obeso, J., Marek, K., Litvan, I., Lang, A. E., et al. (2015) · Movement Disorders
Parkinson's Disease Mechanisms and TreatmentsDeep Brain Stimulation and Movement Disorders
Cited by 7,653
- Verified
Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing results
Goetz, C. G., Tilley, B. C., Shaftman, S. R., Stebbins, G. T., Fahn, S., Martinez‐Martin, P., Poewe, W., Sampaio, C., Stern, M. B., Dodel, R., et al. (2008) · Movement Disorders
Parkinson's Disease Mechanisms and TreatmentsDeep Brain Stimulation and Movement Disorders
Cited by 7,536
- Verified
Parkinson disease
Poewe, W., Seppi, K., Tanner, C. M., Halliday, G. M., Brundin, P., Volkmann, J., Schrag, A.-E., & Lang, A. E. (2017) · Nature Reviews Disease Primers
Parkinson's Disease Mechanisms and TreatmentsDeep Brain Stimulation and Movement Disorders
Cited by 5,415
- Verified
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
Sidransky, E., Nalls, M. A., Aasly, J. O., Aharon-Peretz, J., Annesi, G., Barbosa, E. R., Bar-Shira, A., Berg, D., Bras, J., Brice, A., et al. (2009) · New England Journal of Medicine
Lysosomal Storage Disorders ResearchParkinson's Disease Mechanisms and Treatments
Cited by 2,135
- Verified
Criteria for the diagnosis of corticobasal degeneration
Armstrong, M. J., Litvan, I., Lang, A. E., Bak, T. H., Bhatia, K. P., Borroni, B., Boxer, A. L., Dickson, D. W., Grossman, M., Hallett, M., et al. (2013) · Neurology
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 1,904
- Verified
A Five-Year Study of the Incidence of Dyskinesia in Patients with Early Parkinson's Disease Who Were Treated with Ropinirole or Levodopa
Rascol, O., Brooks, D. J., Korczyn, A. D., De Deyn, P. P., Clarke, C. E., & Lang, A. E. (2000) · New England Journal of Medicine
Parkinson's Disease Mechanisms and TreatmentsDeep Brain Stimulation and Movement Disorders
Cited by 1,539
- Verified
Subthalamic nucleus deep brain stimulation: Summary and meta-analysis of outcomes
Kleiner-Fisman, G., Herzog, J., Fisman, D. N., Tamma, F., Lyons, K. E., Pahwa, R., Lang, A. E., & Deuschl, G. (2006) · Movement Disorders
Deep Brain Stimulation and Movement DisordersObsessive-Compulsive Spectrum Disorders
Cited by 957
- Verified
Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy
Obeso, J. A., Stamelou, M., Goetz, C. G., Poewe, W., Lang, A. E., Weintraub, D., Burn, D., Halliday, G. M., Bezard, E., Przedborski, S., et al. (2017) · Movement Disorders
Parkinson's Disease Mechanisms and TreatmentsNeurology and Historical Studies
Cited by 859
- Verified
Current Concepts in Diagnosis and Treatment of Functional Neurological Disorders
Espay, A. J., Aybek, S., Carson, A., Edwards, M. J., Goldstein, L. H., Hallett, M., LaFaver, K., LaFrance, W. C., Lang, A. E., Nicholson, T., et al. (2018) · JAMA Neurology
Psychosomatic Disorders and Their TreatmentsFibromyalgia and Chronic Fatigue Syndrome Research
Cited by 786
- Verified
Technology in Parkinson’s disease: challenges and opportunities
Espay, A. J., Bonato, P., Nahab, F. B., Maetzler, W., Dean, J. M., Klucken, J., Eskofier, B. M., Merola, A., Horak, F., Lang, A. E., et al. (2016) · Movement Disorders
Parkinson's Disease Mechanisms and TreatmentsDeep Brain Stimulation and Movement Disorders
Cited by 654
- Verified
Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study
Steeves, T. D. L., Miyasaki, J., Zurowski, M., Lang, A. E., Pellecchia, G., Van Eimeren, T., Rusjan, P., Houle, S., & Strafella, A. P. (2009) · Brain
Gambling Behavior and TreatmentsParkinson's Disease Mechanisms and Treatments
Cited by 502
- Verified
Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches
Boxer, A. L., Yu, J.-T., Golbe, L. I., Litvan, I., Lang, A. E., & Höglinger, G. U. (2017) · The Lancet Neurology
Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment Research
Cited by 485
- Verified
Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype
Houlden, H., Baker, M., Morris, H. R., MacDonald, N., Pickering–Brown, S., Adamson, J., Lees, A. J., Rossor, M. N., Quinn, N. P., Kertesz, A., et al. (2001) · Neurology
Alzheimer's disease research and treatmentsParkinson's Disease Mechanisms and Treatments
Cited by 409
- Verified
The microbiome–gut–brain axis in Parkinson disease — from basic research to the clinic
Tan, A. H., Lim, S. Y., & Lang, A. E. (2022) · Nature Reviews Neurology
Parkinson's Disease Mechanisms and TreatmentsGut microbiota and health
Cited by 392
- Verified
Practical guidelines for managing adults with 22q11.2 deletion syndrome
Fung, W. L. A., Butcher, N. J., Costain, G., Andrade, D. M., Boot, E., Chow, E. W. C., Chung, B., Cytrynbaum, C., Faghfoury, H., Fishman, L., et al. (2015) · Genetics in Medicine
Genomic variations and chromosomal abnormalitiesImmunodeficiency and Autoimmune Disorders
Cited by 312
- Verified
Contemporary assessment and pharmacotherapy of Tourette syndrome
Scahill, L., Erenberg, G., Berlin, C. M., Budman, C., Coffey, B. J., Jankovic, J., Kiessling, L., King, R. A., Kurlan, R., Lang, A., et al. (2006) · NeuroRX
Obsessive-Compulsive Spectrum DisordersAttention Deficit Hyperactivity Disorder
Cited by 300
- Verified
Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial
Boxer, A. L., Lang, A. E., Grossman, M., Knopman, D. S., Miller, B. L., Schneider, L. S., Doody, R. S., Lees, A., Golbe, L. I., Williams, D. R., et al. (2014) · The Lancet Neurology
Parkinson's Disease Mechanisms and TreatmentsAlzheimer's disease research and treatments
Cited by 294
- Verified
The prion hypothesis in Parkinson's disease: braak to the future
Visanji, N. P., Brooks, P. L., Hazrati, L.-N., & Lang, A. E. (2013) · Acta Neuropathologica Communications
Parkinson's Disease Mechanisms and TreatmentsAlzheimer's disease research and treatments
Cited by 278
- Verified
Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases
Espay, A. J., Vizcarra, J. A., Marsili, L., Lang, A. E., Simon, D. K., Merola, A., Josephs, K. A., Fasano, A., Morgante, F., Savica, R., et al. (2019) · Neurology
Parkinson's Disease Mechanisms and TreatmentsAlzheimer's disease research and treatments
Cited by 274
- Verified
Bioinformatics-Based Identification of Expanded Repeats: A Non-reference Intronic Pentamer Expansion in RFC1 Causes CANVAS
Rafehi, H., Szmulewicz, D. J., Bennett, M. F., Sobreira, N. L. M., Pope, K., Smith, K. R., Gillies, G., Diakumis, P., Dolzhenko, E., Eberle, M. A., et al. (2019) · The American Journal of Human Genetics
Genetic Neurodegenerative DiseasesGenomics and Rare Diseases
Cited by 262
- Verified
Probiotics for Constipation in Parkinson Disease: A Randomized Placebo-Controlled Study
Tan, A. H., Lim, S.-Y., Chong, K. K., A Manap, M. A. A., Hor, J. W., Lim, J. L., Low, S. C., Chong, C. W., Mahadeva, S., & Lang, A. E. (2021) · Neurology
Gastrointestinal motility and disordersParkinson's Disease Mechanisms and Treatments
Cited by 226
- Verified
Deep brain stimulation for Parkinson’s disease dissociates mood and motor circuits: a functional MRI case study
Stefurak, T., Mikulis, D., Mayberg, H., Lang, A. E., Hevenor, S., Pahapill, P., Saint‐Cyr, J., & Lozano, A. (2003) · Movement Disorders
Deep Brain Stimulation and Movement DisordersObsessive-Compulsive Spectrum Disorders
Cited by 215
- Verified
Long-term follow-up of thalamic deep brain stimulation for essential and parkinsonian tremor
Kumar, R., Lozano, A. M., Sime, E., & Lang, A. E. (2003) · Neurology
Deep Brain Stimulation and Movement DisordersObsessive-Compulsive Spectrum Disorders
Cited by 210
- Verified
Deconstructing normal pressure hydrocephalus: ventriculomegaly as early sign of neurodegeneration
Espay, A. J., Da Prat, G. A., Dwivedi, A. K., Rodriguez‐Porcel, F., Vaughan, J. E., Rosso, M., Devoto, J. L., Duker, A. P., Masellis, M., Smith, C. D., et al. (2017) · Annals of Neurology
Cerebrospinal fluid and hydrocephalusNeurosurgical Procedures and Complications
Cited by 208
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free